Cargando…
Does α-Amino-β-methylaminopropionic Acid (BMAA) Play a Role in Neurodegeneration?
The association of α-amino-β-methylaminopropionic acid (BMAA) with elevated incidence of amyotrophic lateral sclerosis/Parkinson’s disease complex (ALS/PDC) was first identified on the island of Guam. BMAA has been shown to be produced across the cyanobacterial order and its detection has been repor...
Autores principales: | Chiu, Alexander S., Gehringer, Michelle M., Welch, Jeffrey H., Neilan, Brett A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3194113/ https://www.ncbi.nlm.nih.gov/pubmed/22016712 http://dx.doi.org/10.3390/ijerph8093728 |
Ejemplares similares
-
Gliotoxicity of the cyanotoxin, β-methyl-amino-(L)-alanine (BMAA)
por: Chiu, Alexander S., et al.
Publicado: (2013) -
Microbial BMAA and the Pathway for Parkinson’s Disease
Neurodegeneration
por: Nunes-Costa, Daniela, et al.
Publicado: (2020) -
Non-Proteinogenic Amino Acid β-N-Methylamino-L-Alanine (BMAA): Bioactivity and Ecological Significance
por: Koksharova, Olga A., et al.
Publicado: (2022) -
Effects of the Toxic Non-Protein Amino Acid β-Methylamino-L-Alanine (BMAA) on Intracellular Amino Acid Levels in Neuroblastoma Cells
por: Violi, Jake P., et al.
Publicado: (2023) -
BMAA, Methylmercury, and Mechanisms of Neurodegeneration in Dolphins: A Natural Model of Toxin Exposure
por: Davis, David A., et al.
Publicado: (2021)